Related Experiment Video

Updated: Mar 23, 2026

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

14.0K

Catechol-grafted dendrimer with a neutral shell allows pH-triggered "off-on" release of bortezomib

Mingming Wang1, Yu Wang2, Naimin Shao1

  • 1Shanghai Key Laboratory of Regulatory Biology, School of Life Sciences, East China Normal University, Shanghai 200241, China.

Journal of Controlled Release : Official Journal of the Controlled Release Society
|March 24, 2016
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Synthesis and Bioconjugation of Thiol-Reactive Reagents for the Creation of Site-Selectively Modified Immunoconjugates
08:47

Synthesis and Bioconjugation of Thiol-Reactive Reagents for the Creation of Site-Selectively Modified Immunoconjugates

Published on: March 6, 2019

10.3K
Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes
07:22

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes

Published on: January 12, 2024

4.8K

Related Experiment Videos

Last Updated: Mar 23, 2026

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

14.0K
Synthesis and Bioconjugation of Thiol-Reactive Reagents for the Creation of Site-Selectively Modified Immunoconjugates
08:47

Synthesis and Bioconjugation of Thiol-Reactive Reagents for the Creation of Site-Selectively Modified Immunoconjugates

Published on: March 6, 2019

10.3K
Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes
07:22

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes

Published on: January 12, 2024

4.8K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Modified-Release Drug Delivery Systems: Stimuli-Activated01:30

Modified-Release Drug Delivery Systems: Stimuli-Activated

111
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
111

Articles linked to this work by shared authors, journal, and citation graph.

Single-cell Atlas Reveals Myelopoietic Bias and Immunosuppressive Reprogramming in Metastatic Bone Marrow Across Cancers.

Genomics, proteomics & bioinformatics·2026

Gait-based diagnostic network for localization and pathological characterization of spine and pelvis diseases.

Medical image analysis·2026

Focal Adhesion Kinase Activation Mediates IQ Motif-Containing GTPase-Activating Protein 3-Promoted Lung Metastasis in Osteosarcoma.

The American journal of pathology·2026

Targeting the Jun-Irf8-CD36 axis attenuates fibrotic scar formation and promotes functional recovery after spinal cord injury.

Burns & trauma·2026

Clinical association between myelodysplastic syndrome and de novo bone metastasis in urothelial carcinoma.

World journal of surgical oncology·2026

AARS1-catalyzed H4K12 lactylation promotes HCC resistance to targeted therapy by activating RAPGEF3-RAP1 signaling.

Cell death & disease·2026

Micro-armory bearing natural killer cells in hydrogel enable durable in situ activation and localized reinvigoration of antitumor cytotoxic immunity.

Journal of controlled release : official journal of the Controlled Release Society·2026

Nitric oxide-assisted lipid nanoparticles amplify mRNA vaccine responses.

Journal of controlled release : official journal of the Controlled Release Society·2026

Rapid Fc-mediated surface modification of liposomes with antibodies for selective targeting of pancreatic tumors.

Journal of controlled release : official journal of the Controlled Release Society·2026

Challenges and approaches to the design of hydrophilic linkers for antibody-drug conjugates.

Journal of controlled release : official journal of the Controlled Release Society·2026

Thermogelling lacrimal duct-applied therapeutic platform for dry eye syndrome.

Journal of controlled release : official journal of the Controlled Release Society·2026

Position-specific polymeric-coated oncolytic adenovirus improves anti-tumor efficacy and evades neutralizing antibodies in pancreatic cancer models.

Journal of controlled release : official journal of the Controlled Release Society·2026

ortho-Halogen substituent design for creating near-infrared color centers in single-walled carbon nanotubes.

Nanoscale·2026

Supramolecularly Stabilized Copper(I) Halides for High-Efficiency Near-Ultraviolet Emission and X-ray Scintillation.

Nano letters·2026

Acoustic Control of Spin States in Diamond Nitrogen-Vacancy Centres.

Nano letters·2026

Rational Ligand Engineering Enables Emission-Tunable Copper Nanoclusters for High-Performance LEDs.

Nano letters·2026

Valence-engineered CuOxvia anion doping to boost nitrate-to-ammonia conversion.

Chemical communications (Cambridge, England)·2026

Electrochemical and Biological Evaluation of Patterned TiO2@TiC-Nanowires for Bio-Interface Electrode.

Small (Weinheim an der Bergstrasse, Germany)·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us